Navigating Non-Conformities in Technical Documentation

Kamiya Crabtree
A compass being used to navigate across mountainous countryside.

This article explores how to effectively manage non-conformities in technical documentation within the context of EU MDR compliance. Learn how to implement corrective and preventive actions (CAPAs) and best practices to enhance product quality and ensure regulatory adherence.

In the highly regulated world of regulatory affairs, technical documentation serves as a cornerstone for ensuring product compliance, safety, and efficacy. Yet even the most meticulously prepared documents can face non-conformities during reviews.

Let’s explore how to manage non-conformities effectively and implement corrective and preventive actions (CAPAs) to enhance the quality of technical documentation.

Understanding Non-Conformities

In the context of the EU Medical Device Regulation (EU MDR), a non-conformance refers to a situation where a medical device, process, or quality management system does not meet the requirements outlined in the regulation (ISO 13485) and the organisation’s aligned procedures. Non-conformities can occur during numerous stages of the medical device lifecycle, including design, manufacturing, post-market surveillance, or quality management, and may include:

  • Incomplete or inaccurate content: Missing critical details like device classifications or clinical data summaries.
  • Inconsistent formatting: Deviations from templates or submission requirements.
  • Outdated references: Use of superseded regulations or standards.

The PIP Scandal: A Wake-Up Call for Managing Non-Conformities

Poly Implant Prothese (PIP) was a French company which manufactured breast implants, and was once the world’s third biggest supplier. The issue arose in 2010, when PIP implants were revealed to be made from cheaper, industrial-grade silicone (that was not approved for medical use), and were rupturing. The silicone gel was known to cause inflammation and possible scarring, and these implants raised concerns over harmful long-term effects. This posed significant risks to patient health, leading to thousands of women receiving defective implants. The scandal highlighted severe flaws in both the manufacturing process and the regulatory oversight of medical devices.

For example, the PIP implants were not subjected to adequate safety testing, and documentation of these test results was either incomplete or absent. The absence of proper validation and testing records left significant gaps in the product’s safety profile. If there had been a comprehensive review of testing protocols and documented evidence of failures or deviations from safety standards, corrective actions could have been taken much earlier.

The PIP scandal serves as a stark reminder of the importance of proper documentation, regulatory compliance, and risk management in the medical device industry. When non-conformities are not adequately identified, documented, or addressed, it can lead to catastrophic results for both patients and manufacturers. The technical documentation for a medical device, such as breast implants, includes crucial elements such as design specifications, materials used, testing procedures, and safety protocols.

A Structured Approach to Corrective and Preventive Actions

When a non-conformance is identified, it is essential to implement appropriate Corrective and Preventive Actions (CAPAs). These actions must address the root cause, prevent recurrence, and ensure compliance with EU MDR requirements. Prompt and effective resolution of non-conformances is crucial to maintaining product quality, ensuring patient safety, and achieving regulatory compliance in the EU market.

A CAPA is a systematic approach that organisations use to identify, investigate, and address issues or non-conformities within their processes, products or services. The goal of CAPA is to both correct problems and implement measures to prevent them from happening again in the future. CAPA is made up of two components:

  • Corrective Action (CA): Corrective Action addresses existing problems, non-conformities or deviations identified. It involves immediate or short-term actions to rectify the issue, mitigate any negative impacts, and prevent recurrence.
  • Preventive Action (PA): Preventive Action aims to identify and eliminate potential causes of problems or non-conformities before they occur. It is a proactive approach to prevent similar issues from arising in the future.

The CAPA process typically involves the following steps:

  • Identification and Reporting: Identifying the problem, non-conformity, or deviation, and reporting it.
  • Investigation and Analysis: Conducting a thorough investigation to determine the root cause of the issue.
  • Action Plan Development: Developing a corrective action plan to address the immediate issue. Then a preventive action plan to mitigate future occurrences.
  • Implementation: Implementing the corrective actions and preventive actions according to the action plans.
  • Verification: Verifying that the actions taken have effectively addressed the issues and prevented recurrence.
  • Monitoring and Review: Monitoring the implemented changes to ensure they are sustained. Reviewing the effectiveness of the corrective and preventive actions over time.

Completing a Root Cause Analysis

Root cause analysis goes beyond surface symptoms to uncover the underlying reason for the non-conformance.

There are several techniques that can be used for root cause analysis, such as:

  • 5 Whys: Ask “why” repeatedly. Look into the successive layers of cause and effect until reaching the fundamental reason.
  • Fishbone Diagram (Ishikawa or Cause and Effect Diagram): Identify potential causes categorised into different factors.
  • Failure Mode and Effects Analysis (FMEA): Evaluate potential failure modes and their causes, effects, and severity. Prioritise corrective and preventive actions.

Best Practices for Managing Non-Conformities

Implementing the following best practices can help organisations address issues proactively and prevent recurrence, including:

  • Conduct Regular Audits: Routinely review technical documentation to detect and resolve discrepancies before they escalate.
  • Foster Cross-Functional Collaboration: Encourage seamless cooperation between regulatory, quality assurance, and R&D teams to enhance compliance and efficiency.
  • Strengthen Regulatory Knowledge: Equip teams with a deep understanding of regulatory requirements and quality standards to minimise errors and improve compliance.
  • Leverage Corrective Action Requests (CARs) for Improvement: View CARs as opportunities to refine processes. Analysing non-conformance trends can reveal systemic issues that require long-term solutions.

In the fast-evolving regulatory landscape, maintaining robust processes for handling non-conformities is a critical skill for any regulatory professional. Let’s embrace these challenges as opportunities to build stronger, more compliant systems. Get in touch for tailored solutions that ensure your technical documentation meets the latest standards.

Related articles

  1. US and EU flags on poles alongside each other.

    Clinical Evidence under EU MDR: Leveraging FDA Clinical Data to Streamline EU MDR Compliance

    FDA approval alone is not sufficient for European market access - a theme we explore futher in this article and the accompanying webinar.

    Chandini Valiya Kizhakkeveetil Chandini Valiya Kizhakkeveetil Regulatory Medical Writer
  2. An AI-generated image of 3 people in an office in front of a whiteboard with the words 'Medical Device Market Entry Strategy' written above a world map.

    EU MDR & NHS DTAC Cybersecurity Requirements for UK Market Entry

    This guest article from our partner Cyber Alchemy shows you how to build cybersecurity evidence for the EU MDR and NHS DTAC.

    Luke Hill Luke Hill Co-Founder of Cyber Alchemy
  3. An illustration showing a GPS-driven navigation route superimposed upon someone using a laptop.

    Where to Launch First? A MedTech Founder's Regulatory Roadmap to the EU, UK and US

    Cyber Alchemy × Mantra Systems — Episode 1: All three markets operate under different regulatory systems and place different demands on manufacturers.

    Ronghe Xu Ronghe Xu Regulatory Medical Writer & Strategic BD Lead China
  4. A woman uses an inhaler.

    Navigating EU MDR Article 117: A Practical Guide to Drug-Device Combination Product Submissions

    Implementation of the EU MDR 2017/745 has brought significant changes.

    Chandini Valiya Kizhakkeveetil Chandini Valiya Kizhakkeveetil Regulatory Medical Writer
  5. Collage art showing a pair of binoculars, an analogy for surveillance.

    How EU MDR Post Market Surveillance differs from FDA post-market expectations

    We compare manufacturer-specific post-market obligations across both regulatory systems.

    Dr Gayle Buchel Dr Gayle Buchel Chief Medical Writer
  6. An arrow arcs from the US over to Europe.

    How EU device classification differs from the US - Are you Prepared?

    Did you know an FDA Class II medical device could be immediately considered as a high-risk Class III device under European Union regulations?

    Gabriela Cardoso Gabriela Cardoso Regulatory Medical Writer
  7. A magnifying glass inspecting a number of wooden cubes with question marks upon them laid upon a blue table. The wooden cube under the magnifying glass has a lightbulb painted on it.

    Fixing the MDR and IVDR? The Commission’s Proposed Amendments and What They Mean for Manufacturers

    Exploring the key elements of this proposal.

    Chandini Valiya Kizhakkeveetil Chandini Valiya Kizhakkeveetil Regulatory Medical Writer
  8. Two arms point at a sign and hold a question mark, in an abstract pop-art style.

    Regulatory Reset? The EU’s Proposed Changes to MDR and IVDR Explained

    Changes published in December 2025 aim to streamline EU medical device and in vitro diagnostics. We explain who is impacted and how.

    Dr Gayle Buchel Dr Gayle Buchel Chief Medical Writer
  9. A pair of glasses rests on an eye test chart.

    Did You Know Your Glasses Were a Medical Device? A Regulatory Guide for Manufacturers

    The importance of correct classification and our recommended path to avoid common ophthalmic device 'gotchas'.

    Gabriela Cardoso Gabriela Cardoso Regulatory Medical Writer

More articles

Need help producing compliant CEPs & CERs? We are offering FREE CEPs to 5 qualifying applicants per week

Get your free CEP